This issue of the ECDC Communicable Disease Threats Report (CDTR) the period 21-27 January 2024 and includes updates on SARS-CoV-2, influenza, cholera, chikungunya, dengue and zika.
More frequent heatwaves and flooding, longer and hotter summers - all of these factors created more favourable conditions for mosquitos to thrive. Watch our animation, learn more and stay safe!
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 10-16 December 2023 and includes updates on measles, chikungunya, dengue, SARS-CoV-2, diphtheria, West Nile virus, respiratory virus epidemiology and influenza.
A joint study of the National Public Health Organization in Greece (NPHO) and the European Centre for Disease Prevention and Control (ECDC) conducted in 15 Greek hospitals in 2022 sheds light on the rapid spread of carbapenemase-producing, highly drug-resistant Klebsiella pneumoniae sequence type (ST) 39, following its initial documentation in a European-wide genomic survey in 2019.
The main aim of the genomic study described in this surveillance report was to determine the distribution of the highly drug-resistant clade of Klebsiella pneumoniae (sequence type (ST) 39 in Greek hospitals in 2022.
In 2023 and until the beginning of November, over 4.5 million cases and over 4 000 dengue-related deaths have been reported from 80 countries/territories globally.
In 2023 and until the beginning of November, over 4.5 million cases and over 4 000 dengue-related deaths have been reported from 80 countries/territories globally.